- All proposals of the Board of Directors approved
- Audited statutory interim financial statements (standalone financial statements) of the Company as of 31 October 2021 approved
- Share capital reduction by cancellation of 53,309,000 bearer shares with a nominal value of CHF 1 each approved
Basel, 26 November 2021 - On 4 November 2021, Roche.
All trademarks used or mentioned in this release are protected by law.
Roche Group Media Relations
Phone: +41 61 688 8888 / e-mail: media.relations@roche.com
| Dr. Nicolas Dunant Phone: +41 61 687 05 17 | Sileia Urech Phone: +41 79 935 81 48 |
| Dr. Barbara von Schnurbein Phone: +41 61 687 89 67 | Karsten Kleine Phone: +41 61 682 28 31 |
| Nina Mählitz Phone: +41 79 327 54 74 | Nathalie Meetz Phone: +41 61 687 43 05 |
Attachment
- 26112021_MR_EGM2021 (https://ml-eu.globenewswire.com/Resource/Download/35252ae0-d971-4116-af90-e745b066d671)
